Christine Gregoire, governor, Washington State (USA), has visited Noida headquarter of Jubilant Life Sciences Ltd. The company has a key relationship with the state of Washington, its US FDA approved manufacturing facility for sterile injectables and allergy therapy products is based in Spokane (Washington).

Commenting on the visit, the Governor Christine Gregoire, said, “We come here to India as the first delegation ever to visit from the state of Washington. We have already developed a wonderful partnership and we are so proud to be the home of Jubilant in Spokane, Washington. By investing in our community and technical colleges, as well as our research universities, we can provide the skilled workforce that Jubilant needs to prosper, resulting in more family-wage jobs in our community.”

Commenting on the development, Shyam S Bhartia, chairman and managing director and Hari S Bhartia, co-chairman and managing director, said, “It’s important for Jubilant, being an integrated pharmaceutical player to have strong presence in USA, the largest global pharmaceuticals market. Around 50 per cent of our assets are in North America with investments of close to $300 mn in USA, providing job opportunities to about 1000 people. Currently we have two US FDA approved facilities, one for sterile injectables in Spokane, Washington and one for oral dosage formulations in Salisbury, Maryland, besides clinical research business in New Jersey. We enjoy globally recognised leadership positions as quality manufacturer and innovative solutions provider. We have a strong platform to consolidate this position for further growth thereby providing value creation opportunities for all stakeholders.”

In Spokane, Jubilant Life Sciences operates through its subsidiary, Jubilant HollisterStier Laboratories, LLC. It has 610 employees working in this facility. The Company has leadership position in the contract manufacturing of sterile injectables and allergenic extracts business in the US.

"Our operations in Spokane serve as a critical basis for our manufacturing and R&D operations in sterile injectables and allergy products. We look forward to working with the State and local officials in supporting our growth plans,” said Marcelo Morales, CEO, Jubilant HollisterStier.